Android app Apple app link

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

By Yahoo! Finance   |   1 month ago
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

Amgen and AstraZeneca released promising results from the Phase III WAYPOINT trial of Tezspire for treating chronic rhinosinusitis with nasal polyps.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.